ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.
ADARx Pharmaceuticals was founded in 2019 by Zhen Li.
1282 health care and life sciences companies are in the directory, 519 of them in the same 11-50 employee range and 28 based in Greater San Diego Area.
ADARx Pharmaceuticals may be growing as it has successfully secured a significant amount of funding, with $200 million raised in an oversubscribed Series C financing round. This influx of capital is intended to advance the company's clinical programs, which includes the development of ADX-324, a treatment in their pipeline. The ability to raise funds beyond the initial target suggests strong investor confidence in the company's potential and its ongoing projects.
“Amplifying Science Leveraging our decades of siRNA drug development experience and proprietary technologies, we are focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. Learn more about our next-generation research technologies.” adarx.com
ADARx Pharmaceuticals has a 11-50 person team and operates in biotechnology, listed under Greater San Diego Area, and has been around since 2019. Its founder is Zhen Li and it has raised $332 million over 5 rounds.
11-50 employees · abferopharmaceuticals.com
11-50 employees · artbio.com
51-100 employees · aoporphan.com
101-250 employees · aveooncology.com
1-10 employees · aeonbiopharma.com
11-50 employees · 8five8tx.com
11-50 employees · 23strands.com
11-50 employees · acllaboratories.com
11-50 employees · 4cpharma.com
11-50 employees · advancells.com
Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.